UPDATE: In a groundbreaking move, President Donald Trump has officially reclassified marijuana from a Schedule I drug to a Schedule III drug as of October 19, 2023. This pivotal decision shifts cannabis from a category that includes heroin to one akin to painkillers like Tylenol with codeine, marking a dramatic change in the federal government’s approach to cannabis.
This reclassification is set to have profound implications for both the cannabis industry and medical research in Michigan and beyond. “This classification order will make it far easier to conduct marijuana-related medical research,” Trump stated during the signing ceremony in the Oval Office. Researchers like Hillary Marusak from Wayne State University are optimistic, highlighting that the change will facilitate vital studies on the benefits and potential risks of marijuana. “It’s actually a really exciting treatment target for things like anxiety and post-traumatic stress disorder,” she added.
The implications of this executive order extend beyond research. For cannabis businesses, the reclassification could mean major financial relief. Currently, Section 280-E of the IRS tax code limits tax deductions for cannabis companies, making them one of the most heavily taxed industries in the U.S. “Millions and millions of dollars that companies were paying that now they won’t have to pay anymore,” said Nick Hannawa, chief legal counsel at Puff Cannabis Company.
However, this order does not equate to federal legalization of marijuana. Challenges in banking remain, as compliance costs continue to deter major financial institutions from entering the cannabis space. “It will change things over time, but it won’t happen overnight,” cautioned Ross Sloan, senior vice president for cannabis banking at Dart Bank.
Despite the optimism from many in the cannabis community, several Republican lawmakers have expressed disapproval of Trump’s decision. Senators Cynthia Lummis (WY), John Hoeven (ND), and Lindsey Graham (SC) have raised concerns about the potential risks, particularly for youth.
As the cannabis industry anticipates the effects of this historic reclassification, attention will now turn to the potential passage of the SAFER Banking Act, which aims to further ease banking restrictions for cannabis companies. The landscape of the cannabis industry in Michigan and the U.S. is on the cusp of significant change, and stakeholders are closely watching these developments.
With this urgent update, the cannabis sector braces for a transformative period that could redefine its future.
